$ERAS 4 SEC Filings

Filed On	Filing
12 Aug 2026	Form 4: Fuchs Charles S., President, R&D Granted 1,300,000 Stock option (right to buy)
29 Jun 2026	Form 4: Start Valerie Denise Harding, Director Granted 29,888 Stock option (right to buy)
29 Jun 2026	Form 4: Liu Jean I, Director Granted 29,888 Stock option (right to buy)
29 Jun 2026	Form 4: Multani Pratik S, Director Granted 29,888 Stock option (right to buy)
29 Jun 2026	Form 4: Casdin Alexander W., Director Granted 29,888 Stock option (right to buy)
29 Jun 2026	Form 4: Hambleton Julie, Director Granted 29,888 Stock option (right to buy)
29 Jun 2026	Form 4: Bristol James Arthur, Director Granted 29,888 Stock option (right to buy)
03 Apr 2026	Form 4: Garner Ebun, Chief Legal Officer Received 80,000 shares by exercise or conversion ($136K) · Sold 80,000 shares ($1.31M)
06 Mar 2026	Form 4: Morris Shannon, Chief Medical Officer Exercised 20,000 Stock Option (right to buy) · Received 20,000 shares by exercise or conversion ($34K) · Sold 20,000 shares ($301K)
30 Jan 2026	Form 4: Lim Jonathan E, Director Granted 2,000,000 Stock option (right to buy)
30 Jan 2026	Form 4: Chacko David M., CFO and CBO Acquired 17,793 shares (Other Transaction) ($21.3K) · Granted 640,000 Stock option (right to buy)
30 Jan 2026	Form 4: Morris Shannon, Chief Medical Officer Granted 625,000 Stock option (right to buy)
30 Jan 2026	Form 4: Varney Michael David, Director Granted 96,000 Stock option (right to buy)
30 Jan 2026	Form 4: Garner Ebun, General Counsel & Corp. Sec. Granted 560,000 Stock option (right to buy)
08 Jan 2026	Form 4: Garner Ebun, General Counsel & Corp. Sec. Exercised 120,000 Stock Option (right to buy) · Received 3,902 shares as a grant or award ($4.66K) · Received 120,000 shares by exercise or conversion ($204K) · 1 more
05 Jan 2026	Form 4: Bristol James Arthur, Director Granted 37,762 Stock Option (right to buy)
05 Jan 2026	Form 4: Liu Jean I, Director Granted 20,617 Stock Option (right to buy)
05 Jan 2026	Form 4: Multani Pratik S, Director Granted 19,532 Stock Option (right to buy)
05 Jan 2026	Form 4: Start Valerie Denise Harding, Director Granted 24,306 Stock Option (right to buy)
05 Jan 2026	Form 4: Casdin Alexander W., Director Granted 23,872 Stock Option (right to buy)

Comments